Effectiveness and safety of SARS-CoV-2 vaccine in real-world studies: a systematic review and meta-analysis
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Effectiveness and safety of SARS-CoV-2 vaccine in real-world studies: a systematic review and meta-analysis
Authors
Keywords
-
Journal
Infectious Diseases of Poverty
Volume 10, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2021-11-15
DOI
10.1186/s40249-021-00915-3
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Fast-spreading COVID variant can elude immune responses
- (2021) Ewen Callaway NATURE
- New variant of SARS-CoV-2 in UK causes surge of COVID-19
- (2021) Tony Kirby Lancet Respiratory Medicine
- BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Mass Vaccination Setting
- (2021) Noa Dagan et al. NEW ENGLAND JOURNAL OF MEDICINE
- Delayed Second Dose versus Standard Regimen for Covid-19 Vaccination
- (2021) Siri R. Kadire et al. NEW ENGLAND JOURNAL OF MEDICINE
- First Month of COVID-19 Vaccine Safety Monitoring — United States, December 14, 2020–January 13, 2021
- (2021) Julianne Gee et al. MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT
- Safety of the first dose of mRNA SARS-CoV-2 vaccines in patients with rheumatic and musculoskeletal diseases
- (2021) Caoilfhionn M Connolly et al. ANNALS OF THE RHEUMATIC DISEASES
- The effectiveness of the TWO-DOSE BNT162b2 vaccine: analysis of real-world data
- (2021) Gabriel Chodick et al. CLINICAL INFECTIOUS DISEASES
- Effectiveness of mRNA COVID-19 vaccines against SARS-CoV-2 infection in a cohort of healthcare personnel
- (2021) Melanie D Swift et al. CLINICAL INFECTIOUS DISEASES
- Safety of an inactivated SARS-CoV-2 vaccine among healthcare workers in China
- (2021) Mei-Xian Zhang et al. Expert Review of Vaccines
- Association Between Vaccination With BNT162b2 and Incidence of Symptomatic and Asymptomatic SARS-CoV-2 Infections Among Health Care Workers
- (2021) Yoel Angel et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- The challenge of emerging SARS-CoV-2 mutants to vaccine development
- (2021) Rong Li et al. Journal of Genetics and Genomics
- BNT162b2 vaccination in heart transplant recipients: clinical experience and antibody response
- (2021) Yael Peled et al. JOURNAL OF HEART AND LUNG TRANSPLANTATION
- Safety and immunogenicity of COVID-19 vaccination in patients with non-alcoholic fatty liver disease (CHESS2101): a multicenter study
- (2021) Jitao Wang et al. JOURNAL OF HEPATOLOGY
- BNT162b2 mRNA Covid-19 vaccine effectiveness in the prevention of SARS-CoV-2 infection: a preliminary report
- (2021) Francesco Paolo Bianchi et al. JOURNAL OF INFECTIOUS DISEASES
- Interim findings from first-dose mass COVID-19 vaccination roll-out and COVID-19 hospital admissions in Scotland: a national prospective cohort study
- (2021) Eleftheria Vasileiou et al. LANCET
- Impact and effectiveness of mRNA BNT162b2 vaccine against SARS-CoV-2 infections and COVID-19 cases, hospitalisations, and deaths following a nationwide vaccination campaign in Israel: an observational study using national surveillance data
- (2021) Eric J Haas et al. LANCET
- COVID-19 vaccine coverage in health-care workers in England and effectiveness of BNT162b2 mRNA vaccine against infection (SIREN): a prospective, multicentre, cohort study
- (2021) Victoria Jane Hall et al. LANCET
- Safety and immunogenicity of one versus two doses of the COVID-19 vaccine BNT162b2 for patients with cancer: interim analysis of a prospective observational study
- (2021) Leticia Monin et al. LANCET ONCOLOGY
- Preliminary Findings of mRNA Covid-19 Vaccine Safety in Pregnant Persons
- (2021) Tom T. Shimabukuro et al. NEW ENGLAND JOURNAL OF MEDICINE
- Effectiveness of the BNT162b2 Covid-19 Vaccine against the B.1.1.7 and B.1.351 Variants
- (2021) Laith J. Abu-Raddad et al. NEW ENGLAND JOURNAL OF MEDICINE
- Safety and Reactogenicity of 2 Doses of SARS-CoV-2 Vaccination in Solid Organ Transplant Recipients
- (2021) Michael T. Ou et al. TRANSPLANTATION
- Effectiveness of the Pfizer-BioNTech and Oxford-AstraZeneca vaccines on covid-19 related symptoms, hospital admissions, and mortality in older adults in England: test negative case-control study
- (2021) Jamie Lopez Bernal et al. BMJ-British Medical Journal
- Delaying the second dose of covid-19 vaccines
- (2021) Dominic Pimenta et al. BMJ-British Medical Journal
- Safety Monitoring of the Janssen (Johnson & Johnson) COVID-19 Vaccine — United States, March–April 2021
- (2021) David K. Shay et al. MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT
- Interim Estimates of Vaccine Effectiveness of Pfizer-BioNTech and Moderna COVID-19 Vaccines Among Health Care Personnel — 33 U.S. Sites, January–March 2021
- (2021) Tamara Pilishvili et al. MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT
- Effectiveness of Pfizer-BioNTech and Moderna Vaccines Against COVID-19 Among Hospitalized Adults Aged ≥65 Years — United States, January–March 2021
- (2021) Mark W. Tenforde et al. MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT
- Effectiveness of the Pfizer-BioNTech COVID-19 Vaccine Among Residents of Two Skilled Nursing Facilities Experiencing COVID-19 Outbreaks — Connecticut, December 2020–February 2021
- (2021) Amadea Britton et al. MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT
- COVID-19 Outbreak Associated with a SARS-CoV-2 R.1 Lineage Variant in a Skilled Nursing Facility After Vaccination Program — Kentucky, March 2021
- (2021) Alyson M. Cavanaugh et al. MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT
- Efficacy and Safety of COVID-19 Vaccines: A Systematic Review and Meta-Analysis of Randomized Clinical Trials
- (2021) Ali Pormohammad et al. Vaccines
- Mortality Rate and Characteristics of Deaths Following COVID-19 Vaccination
- (2021) Gang Lv et al. Frontiers in Medicine
- Immunogenicity and safety of the BNT162b2 mRNA COVID-19 vaccine in adult patients with autoimmune inflammatory rheumatic diseases and in the general population: a multicentre study
- (2021) Victoria Furer et al. ANNALS OF THE RHEUMATIC DISEASES
- COVID-19 Outbreak Associated with a SARS-CoV-2 P.1 Lineage in a Long-Term Care Home after Implementation of a Vaccination Program – Ontario, April-May 2021
- (2021) Chantal Williams et al. CLINICAL INFECTIOUS DISEASES
- Single-dose mRNA Vaccine Effectiveness Against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), Including Alpha and Gamma Variants: A Test-negative Design in Adults 70 Years and Older in British Columbia, Canada
- (2021) Danuta M Skowronski et al. CLINICAL INFECTIOUS DISEASES
- The BNT162b2 mRNA COVID-19 vaccine in adolescents and young adults with cancer: A monocentric experience
- (2021) Gabriel Revon-Riviere et al. EUROPEAN JOURNAL OF CANCER
- Effectiveness of COVID-19 vaccines in preventing SARS-CoV-2 infection and hospitalisation, Navarre, Spain, January to April 2021
- (2021) Iván Martínez-Baz et al. Eurosurveillance
- Effectiveness of mRNA COVID-19 vaccines in preventing SARS-CoV-2 infections and COVID-19 hospitalisations and deaths in elderly long-term care facility residents, Spain, weeks 53 2020 to 13 2021
- (2021) Clara Mazagatos et al. Eurosurveillance
- Effectiveness of SARS-CoV-2 Vaccination in a Veterans Affairs Cohort of Patients With Inflammatory Bowel Disease With Diverse Exposure to Immunosuppressive Medications
- (2021) Nabeel Khan et al. GASTROENTEROLOGY
- Coronavirus disease 2019 (COVID-19) mRNA vaccine effectiveness in asymptomatic healthcare workers
- (2021) Pablo Knobel et al. INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY
- Third dose of the BNT162b2 vaccine in heart transplant recipients: Immunogenicity and clinical experience
- (2021) Yael Peled et al. JOURNAL OF HEART AND LUNG TRANSPLANTATION
- Safety and effectiveness of SARS‐CoV‐2 vaccines: A systematic review and meta‐analysis
- (2021) Yunzhi Ling et al. JOURNAL OF MEDICAL VIROLOGY
- High anaphylaxis rates following vaccination with the Pfizer BNT162b2 mRNA vaccine against COVID-19 in Japanese healthcare workers: a secondary analysis of initial post-approval safety data
- (2021) Takanao Hashimoto et al. JOURNAL OF TRAVEL MEDICINE
- Reactogenicity and immunogenicity after a late second dose or a third dose of ChAdOx1 nCoV-19 in the UK: a substudy of two randomised controlled trials (COV001 and COV002)
- (2021) Amy Flaxman et al. LANCET
- SARS-CoV-2 Delta VOC in Scotland: demographics, risk of hospital admission, and vaccine effectiveness
- (2021) Aziz Sheikh et al. LANCET
- Efficacy and safety of an inactivated whole-virion SARS-CoV-2 vaccine (CoronaVac): interim results of a double-blind, randomised, placebo-controlled, phase 3 trial in Turkey
- (2021) Mine Durusu Tanriover et al. LANCET
- Effectiveness of BNT162b2 and ChAdOx1 nCoV-19 COVID-19 vaccination at preventing hospitalisations in people aged at least 80 years: a test-negative, case-control study
- (2021) Catherine Hyams et al. LANCET INFECTIOUS DISEASES
- Vaccine effectiveness of the first dose of ChAdOx1 nCoV-19 and BNT162b2 against SARS-CoV-2 infection in residents of long-term care facilities in England (VIVALDI): a prospective cohort study
- (2021) Madhumita Shrotri et al. LANCET INFECTIOUS DISEASES
- How the Delta variant achieves its ultrafast spread
- (2021) Sara Reardon NATURE
- mRNA-1273 COVID-19 vaccine effectiveness against the B.1.1.7 and B.1.351 variants and severe COVID-19 disease in Qatar
- (2021) Hiam Chemaitelly et al. NATURE MEDICINE
- Effectiveness of Covid-19 Vaccines against the B.1.617.2 (Delta) Variant
- (2021) Jamie Lopez Bernal et al. NEW ENGLAND JOURNAL OF MEDICINE
- Effectiveness of an Inactivated SARS-CoV-2 Vaccine in Chile
- (2021) Alejandro Jara et al. NEW ENGLAND JOURNAL OF MEDICINE
- Protection of BNT162b2 Vaccine Booster against Covid-19 in Israel
- (2021) Yinon M. Bar-On et al. NEW ENGLAND JOURNAL OF MEDICINE
- SARS-CoV-2 Variants in Patients with Immunosuppression
- (2021) Lawrence Corey et al. NEW ENGLAND JOURNAL OF MEDICINE
- Prevention and Attenuation of Covid-19 with the BNT162b2 and mRNA-1273 Vaccines
- (2021) Mark G. Thompson et al. NEW ENGLAND JOURNAL OF MEDICINE
- Covid-19 Breakthrough Infections in Vaccinated Health Care Workers
- (2021) Moriah Bergwerk et al. NEW ENGLAND JOURNAL OF MEDICINE
- Efficacy of the mRNA-1273 SARS-CoV-2 Vaccine at Completion of Blinded Phase
- (2021) Hana M. El Sahly et al. NEW ENGLAND JOURNAL OF MEDICINE
- Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine through 6 Months
- (2021) Stephen J. Thomas et al. NEW ENGLAND JOURNAL OF MEDICINE
- Oxford–AstraZeneca COVID-19 vaccine: need of a reasoned and effective vaccine campaign
- (2021) A. Vallée et al. PUBLIC HEALTH
- Safety of the ChAdOx1 nCoV-19 and the BBV152 vaccines in 724 patients with rheumatic diseases: a post-vaccination cross-sectional survey
- (2021) Somy Cherian et al. RHEUMATOLOGY INTERNATIONAL
- Short‐term outcome of pregnant women vaccinated with BNT162b2 mRNA COVID ‐19 vaccine
- (2021) S. Bookstein Peretz et al. ULTRASOUND IN OBSTETRICS & GYNECOLOGY
- Tolerance of BNT162b2 mRNA COVI-19 vaccine in patients with a medical history of COVID-19 disease: A case control study
- (2021) Aurelie Baldolli et al. VACCINE
- BNT162b2 vaccine uptake and effectiveness in UK healthcare workers – a single centre cohort study
- (2021) Tariq Azamgarhi et al. Nature Communications
- A rational strategy to support approved COVID-19 vaccines prioritization
- (2021) Javier Burgos-Salcedo Human Vaccines & Immunotherapeutics
- Safety of SARS-CoV-2 vaccines: a systematic review and meta-analysis of randomized controlled trials
- (2021) Musha Chen et al. Infectious Diseases of Poverty
- Real-world effectiveness of BNT162b2 mRNA vaccine: a meta-analysis of large observational studies
- (2021) Chia Siang Kow et al. INFLAMMOPHARMACOLOGY
- Safety of BNT162b2 mRNA COVID-19 vaccine in patients with mast cell disorders
- (2021) Yossi Rosman et al. Journal of Allergy and Clinical Immunology-In Practice
- Serologic Status and Toxic Effects of the SARS-CoV-2 BNT162b2 Vaccine in Patients Undergoing Treatment for Cancer
- (2021) Tal Goshen-Lago et al. JAMA Oncology
- Prevalence and Risk Factors of CoronaVac Side Effects: An Independent Cross-Sectional Study among Healthcare Workers in Turkey
- (2021) Abanoub Riad et al. Journal of Clinical Medicine
- BNT162b2 Vaccine Effectiveness in Preventing Asymptomatic Infection With SARS-CoV-2 Virus: A Nationwide Historical Cohort Study
- (2021) Galia Zacay et al. Open Forum Infectious Diseases
- Evaluation of Side Effects Associated with COVID-19 Vaccines in Saudi Arabia
- (2021) Abdulaziz Alhazmi et al. Vaccines
- Safety of ChAdOx1 nCoV-19 Vaccine: Independent Evidence from Two EU States
- (2021) Abanoub Riad et al. Vaccines
- Interim Estimates of COVID-19 Vaccine Effectiveness in a Mass Vaccination Setting: Data from an Italian Province
- (2021) Maria Elena Flacco et al. Vaccines
- Assessment of Effectiveness of 1 Dose of BNT162b2 Vaccine for SARS-CoV-2 Infection 13 to 24 Days After Immunization
- (2021) Gabriel Chodick et al. JAMA Network Open
- COVID-19 Vaccination among Spanish nephrologists: Results of survey on acceptance and side effects
- (2021) Borja Quiroga et al. Journal of Healthcare Quality Research
- Phase 3 Safety and Efficacy of AZD1222 (ChAdOx1 nCoV-19) Covid-19 Vaccine
- (2021) Ann R. Falsey et al. NEW ENGLAND JOURNAL OF MEDICINE
- Safety Monitoring of an Additional Dose of COVID-19 Vaccine — United States, August 12–September 19, 2021
- (2021) Anne M. Hause et al. MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT
- Immunocompromised patients in the USA and UK should receive third dose of COVID-19 vaccine
- (2021) Bryant Furlow Lancet Rheumatology
- Persistence and Evolution of SARS-CoV-2 in an Immunocompromised Host
- (2020) Bina Choi et al. NEW ENGLAND JOURNAL OF MEDICINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More